Recent Posts

Pages: 1 2 [3] 4 5 ... 10
21
From PubMed (December 22, 2025)--"The effect of dietary interventions on peripheral markers of inflammation among people with multiple sclerosis:  A systematic review and meta-analysis of randomized controlled trials":


https://pubmed.ncbi.nlm.nih.gov/41422672/


This University of Iowa study includes among its authors Dr. Terry Wahls, whose controversial Wahls Protocol may have been among the dietary interventions involved in this study. Interestingly, it looks as if her diet (which is a modified paleo diet) seems not to have shown any effect on peripheral markers of inflammation:


Quote
Seven assessed dietary effects on C-reactive protein (CRP), with five showing reductions, particularly in Mediterranean, plant-based, and calorie-restricted diets, and two showing no between-group differences.

Also, the Conflict of Interest Statement at the end of the abstract reveals that none of the authors except Dr. Wahls has any conflicts to disclose but Dr. Wahls has a surprisingly long list of them.
22
MS - RESEARCH AND NEWS / (Abst.) MS relapse risk factors across treatment eras
« Last post by agate on December 25, 2025, 01:12:24 pm »
A study from researchers at Brigham & Women's Hospital.


From Multiple Sclerosis Journal--Experimental, Translational, and Clinical (October - December 2025)--"Multiple sclerosis relapse risk factors across treatment eras":


https://journals.sagepub.com/doi/full/10.1177/20552173251408619
24
TREATMENTS / (Abst.) Rituximab dosed every 6 months vs. every 12 months in relapsing MS
« Last post by agate on December 23, 2025, 08:56:37 pm »
From PubMed (December 23, 2025)--"Comparative effectiveness of rituximab dosed every 6 and 12 months in relapsing multiple sclerosis":


https://pubmed.ncbi.nlm.nih.gov/41428985/
25
ANNOUNCEMENTS / Festivus, December 23
« Last post by agate on December 22, 2025, 08:53:04 pm »

Festivus, the holiday for the rest of us according to a "Seinfeld" episode, is observed December 23.




FESTIVUS GREETINGS TO EVERYONE!
26
MS - RESEARCH AND NEWS / (Abst.) Dysarthria assessment in MS patients
« Last post by agate on December 21, 2025, 09:14:42 pm »
Anyone with MS who has has dysarthria knows how troubling and frustrating it can be. This abstract indicates that dysarthria is at least being studied.


From PubMed (December 21, 2025)--"Dysarthria assessment in multiple sclerosis patients":


https://pubmed.ncbi.nlm.nih.gov/41420371/


Speech diadochokinesis (from AI):


What it is: The speed and accuracy of repeating syllables ("puh-tuh-kuh," "buttercup") or non-words.
  • What it assesses: Oral motor skill, tongue/lip/jaw coordination, and clarity of speech.
27
From PubMed (December 20, 2025)--"Managing reactivation of multiple sclerosis during treatment with natalizumab":


https://pubmed.ncbi.nlm.nih.gov/41420376/
28
From PubMed (December 19, 2025)--"Association of brain age with physical disability and cognitive impairment in people with multiple sclerosis of the same age":


https://pubmed.ncbi.nlm.nih.gov/41411602/
29
From PubMed (December 18, 2025)--"Efficacy of caffeine supplementation on fatigue in patients with multiple sclerosis:  A randomized double-blind placebo-controlled trial"


https://pubmed.ncbi.nlm.nih.gov/41406935/


I was interested in this because I routinely consume about as much caffeine daily as these patients were being given.  Diet Coke contains slightly more caffeine than Diet Pepsi, FWIW.
30
From PubMed (December 16, 2025)--"Mediterranean diet and risk of multiple sclerosis:  A prospective cohort study":


https://pubmed.ncbi.nlm.nih.gov/41399205/
Pages: 1 2 [3] 4 5 ... 10